The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance

Table 2

Association of miRNA-542-3p expression with clinicopathological parameters in HCC (TCGA).

Clinical parameters	n	miRNA-542-3p relative expression (2^−ΔΔCt)
		Mean ± SD	t	P
Age
<50	8	0.719 ± 0.407	1.273	0.222
≥ 50	45	1.133 ± 0.926
Gender
Male	30	0.883 ± 0.472	−1.6408	0.113
Female	23	1.314 ± 1.190
AFP (ng/mL)
<400	30	1.080 ± 0.843	−0.496	0.623
≥ 400	7	0.917 ± 0.379
Missing data	16
Cirrhosis
Negative	25	0.950 ± 0.529	0.782	0.439
Positive	13	1.088 ± 0.500
Missing data	15
TNM stage
I-II	29	0.872 ± 0.487	1.469	0.149
III-IV	15	1.228 ± 1.1253
Missing data	9
HBV
Negative	31	1.101 ± 1.057	−0.303	0.763
Positive	22	1.027 ± 0.553
Portal invasion
Negative	32	1.295 ± 1.039	−2.059	0.045
Positive	15	0.721 ± 0.390
Missing data	6

Data are presented as mean ± SD. .